NEONC TECHNOLOGIES HOLDINGS, INC.

Neonc Technologies Holdings, Inc.

Biotechnology • Healthcare • Calabasas, CA, United States • NTHI (NGM)

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary brain tumors. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. NeOnc Technologies Holdings, Inc. was incorporated in 2005 and is headquartered in Calabasas, California.

310 663 7831 23975 Park Sorrento, Calabasas, CA 91302, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update - Yahoo Finance
Yahoo Finance • Nov 14
How NeOnc Technologies Holdings Inc. stock valuations compare to rivals - 2026 world cup usa national team third place match young talents counter attacking winner prediction guide - Улправда
Улправда • Jan 6
NeOnc Technologies: From Survival Mode To Expansion Mode (NTHI) - Seeking Alpha
Seeking Alpha • Oct 9
NeOnc Technologies Reports Promising Clinical Trial Results - TipRanks
TipRanks • Dec 17
NTHI IPO News - Biotech NeOnc Technologies' share registration declared effective ahead of Nasdaq direct listing - renaissancecapital.com
renaissancecapital.com • Mar 25

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has NEONC TECHNOLOGIES HOLDINGS, INC. had layoffs?
No layoff events have been recorded for NEONC TECHNOLOGIES HOLDINGS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is NEONC TECHNOLOGIES HOLDINGS, INC. in?
NEONC TECHNOLOGIES HOLDINGS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is NEONC TECHNOLOGIES HOLDINGS, INC. a publicly traded company?
Yes, NEONC TECHNOLOGIES HOLDINGS, INC. is publicly traded under the ticker symbol NTHI on the NGM. The company has a market capitalization of approximately $0.21 billion.
Where is NEONC TECHNOLOGIES HOLDINGS, INC. headquartered?
NEONC TECHNOLOGIES HOLDINGS, INC. is headquartered in Calabasas, CA, United States at 23975 Park Sorrento, Calabasas, CA 91302, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.